Colposcopic Findings of Cervix in VIA Positive Cases in Sylhet MAG Osmani Medical College Hospital, Sylhet, Bangladesh

  • Bushra A Registrar, Department of Obstetrics & Gynaecology, BRB Hospital, Dhaka, Bangladesh
  • Khanam A Assistant Registrar, Department of Obstetrics & Gynaecology, Cumilla Medical College Hospital, Cumilla, Bangladesh
  • Dina US Registrar, Department of Obstetrics & Gynaecology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh
  • Akter T MBBS, FCPS, MCPS, DGO (Obstetrics & Gynaecology), Gynaecologist, CMH, Chittagong, Bangladesh
  • Hossain SN Indoor Medical Officer, Department of Obstetrics & Gynaecology, Dhaka Medical College & Hospital, Dhaka, Bangladesh
  • Zahan N Medical Officer, Barkal Upazila Health Complex, Rangamati, Chattogram, Bangladesh
  • Minkin T Consultant, Department of Obstetrics & Gynaecology, Popular Diagnostic Centre LTD., Kushtia, Bangladesh
Keywords: Colposcopy, Findings of Cervix, VIA Positive Cases, Bangladesh

Abstract

Background: Cervical cancer is a preventable disease as the different screening, diagnostic, and therapeutic procedures are effective. The screening procedures, VIA and Colposcopy are important screening tools in the evaluation of cervical pre-malignant conditions. Materials and Methods: In this cross-sectional observational study two hundred fifty VIA positive women were included. Pregnant women and women who had any operative procedure in the cervix were excluded. VIA positive patient was subjected to colposcopy and cervix was visualized for aceto-white lesion under magnification. Finding of colposcopy was recorded and interpreted using Swede Score.

Results: The age of the VIA positive patients 38.02 ± 10.41 (ranged 22 – 68) years with majority (88.4%) patients were in the age group of 22-50 years. Three-quarter of the women were multiparity. Colposcopic diagnosis was carcinoma in situ I (CINI) in 143 (57.2%) patients, CIN II in 37 (19.2%) patients CIN III in 26 (10.4%) patients, invasive cervical carcinoma in 17 (6.8%) patients and normal finding in 27 (10.8%) cases. Histpathologically 69 (27.6%) patients had carcinoma in situ (CIN) I, 49 (19.6%) patients had CIN II, 26 (10.4%) patients had CIN III, 45 (18.0%) patients had chronic cervicitis, 17 (6.8%) patients had endocervical polyp, 17 (6.8%) patients had invasive cervical carcinoma and biopsy was not done in 27 (10.8%) patients. All colposcopy positive CIN 2 (n=37), CIN 3 (n=26) and invasive carcinoma (n=17) were histopathologically proven CIN 2, CIN 3 and invasive carcinoma respectively. While 143 colposcopy positive CIN 1 cases were histopathologically CIN 1 (48.3%), CIN 2 (8.4%), chronic cervicitis (31.5%), and endocervical polyp (11.9%). Colposcopy correctly diagnosed CIN 2, CIN 3 and invasive carcinoma cervix but about half (52.3%) of the cases of CIN 1 compared to histopathology with overall accuracy of colposcopy was 71.7%. 

Conclusion: This study revealed that colposcopy correctly diagnosed CIN 2, CIN 3 and invasive carcinoma cervix but about half of the cases of CIN 1 compared to histopathology with overall accuracy of colposcopy was 71.7%.  So, colposcopy has a tremendous role in the evaluation of CIN and cervical carcinoma in VIA positive women.

Downloads

Download data is not yet available.

References

1. Shafi MI. Premalignant and malignant disease of the cervix. In: Edmond DK, Less C, Bourne T, editors. Dewhurt’s Text Book of Obstetrics and Gynaecology for Post Graduates, 9th ed. London: Wiley Blackwell. 2018; pp. 614 -24.
2. Campion MJ, Canfell K. Cervical Cancer Screening and Preinvasive Disease. In: Jonathen S, Berek JS, Hacker NF, eds. Barek and Hacker’s Gynaecologic Oncology. 6th ed. Philadelphia: Wolters Kluwer. 2015; p. 242-74.
3. World Health Organization. WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women. World Health Organization, Switzerland. 2013. [cited 2020 Mar 16]. Available from: file:///F:/comprehensive_cervical_cancer_who_ 2013.pdf
4. National Strategy for Cervical Cancer Prevention and Control. National Strategy for Cervical cancer Prevention and Control, Bangladesh, 2017-2020. Directorate General of Health Services, of Health Services Division, Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh. 2017.
5. Banik M, Akhter SN, Kasem SB. Role of Colposcopy for the Detection of Precancerous Lesion of cervix in a Medical College Hospital. ICMHJ 2016; 7(1): 15-9.
6. Khatun SF, Homaira R, Khatun S, Sharmin F, Sharmin, F. Performance of VIA (Visual inspection with acetic acid) and colposcopic biopsy as a method of screening in detecting preinvasion and early cancerous lesion of the cervix. Med Today 2011; 23: 13-4.
7. Sellors JW, Sankaranarayanan R, Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners’ manual. Lyon: IARC Press; 2003; pp. 13-21.
8. Castle PE, Murokora D, Perez C, Alvarez M, Quek SC, Campbell C. Treatment of cervical intraepithelial lesions. Int J Gynaecol Obstet 2017;138 (Suppl 1):20-5.
9. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al; ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Bangladesh. Summary Report 17 June 2019. 2019. [cited 2020 Mar 16].
10. Khan MA, Raja FY, Ishfaq G, Tahir F, Subhan F, Kazi BM. PAP smears screening for precancerous conditions of the cervical cancer. Pak J Med Res 2005;44:111-3.
11. Nayak PK, Mitra S, Agrawal S, Hussain N, Thakur P, Mishra B. Role of various screening techniques in detecting preinvasive lesions of the cervix among symptomatic women and women having unhealthy cervix. J Can Res Ther 2021; 17:180-5.

12. Choudhury FR, Uddin ABMZ, Yusuf MA. Colposcopic findings among VIA positive women: Experience at a Tertiary Care Hospital. J Curr Adv Med Res 2014;1(1):8-12.
13. Denny L. The prevention of cervical cancer in developing countries. BJOG 2005; 112: 1204-12.
14. Richart RM. Natural History of cervical intraepithelial neoplasia. Clin Obstet Gynaecol 1968; 5: 748-84.
15. Akter T, Siddika A, Akter K, Akhter S, Haque MA, Akther N. Colposcopic Findings of Cervix in VIA (Visual Inspection of Cervix by Acetic Acid) Positive Cases at BSMMU, Dhaka, Bangladesh. Sch Int J Obstet Gynec 2022; 5(9):407-13.
16. Velpula S, Yerrapragada M. Comparison of colposcopic findings with acetic acid with histology of colposcopic directed biopsy of premalignant lesions of cervix, A.P. Int J Clin Obstet Gynaecol 2020; 4(1): 325-8.
17. Dorji N, Begum SA, Mahmud T, Amatullah M. Evaluation of Colposcopic and Histopathological Findings in Precancerous Cervical Lesions. Bangladesh Med Res Counc Bull 2020; 46:48-54.
18. Islam F, Sultana CS.Colposcopic Findings for Detecting Pre-invasive Lesion of Cervix Among Visually Inspected Acetic Acid Positive Cases. Bangladesh Med Res Counc Bull 2022; 48: 27-32.
19. Nayani ZS, Hendre PC. Comparision and Correlation of Pap Smear with Colposcopy and Histopathiology in Evaluation of Cervix. J Evol Med Dent Sci 2015; 4(53): 9236-47.
20. Mishra GA, Pimple SA, Gupta SD. Cervical cancer screening in low resource settings: Cytology versus HPV triage for VIA positive women. Int J Prev Med 2019;10:138.
21. Soumah AFM, Bah OH, Bah EM, Camara MK, Keita N, Diallo A. Colposcopy at the University Hospital in Conakry: Role of Colposcopy in Screening and/or Diagnosis of Cervical Cancer in the UTH University Teaching Hospital of Conakry. Open J Obstet Gynecol 2018; 8: 497-504.
22. Bhattachan K, Dangal G, Karki A, Pradhan HK, Shrestha R, Parajuli S, et al. Evaluation of Abnormal Cervix with Visual Inspection under Acetic Acid and Colposcopy. J Nepal Health Res Counc 2019;17(1):76-9.
How to Cite
Bushra, A., Khanam, A., Dina, U. S., Akter, T., Hossain, S. N., Zahan, N., & Minkin, T. (2024). Colposcopic Findings of Cervix in VIA Positive Cases in Sylhet MAG Osmani Medical College Hospital, Sylhet, Bangladesh. Obs Gyne Review: Journal of Obstetric and Gynecology, 10(1), 58-65. Retrieved from https://obstetrics.medresearch.in/index.php/joog/article/view/175
Issue
Vol 10 No 1 (2024): Jan-Dec
Section
Original Article

Copyright (c) 2024 Author (s). Published by Siddharth Health Research and Social Welfare Society

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.